Literature DB >> 28289707

Eomesodermin and T-bet mark developmentally distinct human natural killer cells.

Amélie Collins1,2, Nyanza Rothman2, Kang Liu2, Steven L Reiner1,2.   

Abstract

Immaturity of the immune system of human fetuses and neonates is often invoked to explain their increased susceptibility to infection; however, the development of the fetal innate immune system in early life remains incompletely explored. We now show that the most mature NK cells found in adult (or postnatal) human circulation (CD94-CD16+) are absent during ontogeny. Human fetal NK cells were found to express the 2 signature T-box transcription factors essential for the development of all murine NK and NK-like cells, eomesodermin (Eomes) and T-bet. The single-cell pattern of Eomes and T-bet expression during ontogeny, however, revealed a stereotyped pattern of reciprocal dominance, with immature NK cells expressing higher amounts of Eomes and more mature NK cells marked by greater abundance of T-bet. We also observed a stereotyped pattern of tissue-specific NK cell maturation during human ontogeny, with fetal liver being more restrictive to NK cell maturity than fetal bone barrow, spleen, or lung. These results support the hypothesis that maturation of human NK cells has a discrete restriction until postnatal life, and provide a framework to better understand the increased susceptibility of fetuses and newborns to infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28289707      PMCID: PMC5333970          DOI: 10.1172/jci.insight.90063

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  32 in total

1.  Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections.

Authors:  Jean-Hugues Dalle; José Menezes; Eric Wagner; Marie Blagdon; Josette Champagne; Martin A Champagne; Michel Duval
Journal:  Pediatr Res       Date:  2005-02-17       Impact factor: 3.756

2.  The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.

Authors:  Scott M Gordon; Julie Chaix; Levi J Rupp; Junmin Wu; Sharline Madera; Joseph C Sun; Tullia Lindsten; Steven L Reiner
Journal:  Immunity       Date:  2012-01-18       Impact factor: 31.745

3.  Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.

Authors:  Cathal Harmon; Mark W Robinson; Ronan Fahey; Sarah Whelan; Diarmaid D Houlihan; Justin Geoghegan; Cliona O'Farrelly
Journal:  Eur J Immunol       Date:  2016-09       Impact factor: 5.532

Review 4.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

5.  CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

Authors:  Jianhua Yu; Hsiaoyin C Mao; Min Wei; Tiffany Hughes; Jianying Zhang; Il-kyoo Park; Shujun Liu; Susan McClory; Guido Marcucci; Rossana Trotta; Michael A Caligiuri
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

6.  The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.

Authors:  Bryan M Burt; George Plitas; Zeguo Zhao; Zubin M Bamboat; Hoang M Nguyen; Bo Dupont; Ronald P DeMatteo
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

7.  Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.

Authors:  Gertjan Lugthart; Janine E Melsen; Carly Vervat; Monique M van Ostaijen-Ten Dam; Willem E Corver; Dave L Roelen; Jeroen van Bergen; Maarten J D van Tol; Arjan C Lankester; Marco W Schilham
Journal:  J Immunol       Date:  2016-05-25       Impact factor: 5.422

8.  Defining early human NK cell developmental stages in primary and secondary lymphoid tissues.

Authors:  Diana N Eissens; Jan Spanholtz; Arnold van der Meer; Bram van Cranenbroek; Harry Dolstra; Jaap Kwekkeboom; Frank W M B Preijers; Irma Joosten
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

9.  Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.

Authors:  Joseph J C Thome; Kara L Bickham; Yoshiaki Ohmura; Masaru Kubota; Nobuhide Matsuoka; Claire Gordon; Tomer Granot; Adam Griesemer; Harvey Lerner; Tomoaki Kato; Donna L Farber
Journal:  Nat Med       Date:  2015-12-14       Impact factor: 53.440

10.  CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver.

Authors:  Kerstin A Stegmann; Francis Robertson; Navjyot Hansi; Upkar Gill; Celeste Pallant; Theodoros Christophides; Laura J Pallett; Dimitra Peppa; Claire Dunn; Giuseppe Fusai; Victoria Male; Brian R Davidson; Patrick Kennedy; Mala K Maini
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

View more
  25 in total

1.  Single-Cell RNA-Seq Mapping of Human Thymopoiesis Reveals Lineage Specification Trajectories and a Commitment Spectrum in T Cell Development.

Authors:  Justin Le; Jeong Eun Park; Vi Luan Ha; Annie Luong; Sergio Branciamore; Andrei S Rodin; Grigoriy Gogoshin; Fan Li; Yong-Hwee Eddie Loh; Virginia Camacho; Sweta B Patel; Robert S Welner; Chintan Parekh
Journal:  Immunity       Date:  2020-06-16       Impact factor: 31.745

Review 2.  ILC3 in Axial Spondyloarthritis: the Gut Angle.

Authors:  Daniele Mauro; Federica Macaluso; Serena Fasano; Riccardo Alessandro; Francesco Ciccia
Journal:  Curr Rheumatol Rep       Date:  2019-06-13       Impact factor: 4.592

3.  The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

Authors:  Sigrid Wahlen; Filip Matthijssens; Wouter Van Loocke; Sylvie Taveirne; Laura Kiekens; Eva Persyn; Els Van Ammel; Zenzi De Vos; Stijn De Munter; Patrick Matthys; Filip Van Nieuwerburgh; Tom Taghon; Bart Vandekerckhove; Pieter Van Vlierberghe; Georges Leclercq
Journal:  Elife       Date:  2022-07-06       Impact factor: 8.713

4.  CXCR6+ and NKG2C+ Natural Killer Cells Are Distinct With Unique Phenotypic and Functional Attributes Following Bone Marrow Transplantation.

Authors:  Kevin Aviles-Padilla; Laura S Angelo; Dwight Fan; Silke Paust
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

5.  Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation.

Authors:  Difeng Fang; Kairong Cui; Yaqiang Cao; Mingzhu Zheng; Takeshi Kawabe; Gangqing Hu; Jaspal S Khillan; Dan Li; Chao Zhong; Dragana Jankovic; Alan Sher; Keji Zhao; Jinfang Zhu
Journal:  Immunity       Date:  2022-04-04       Impact factor: 43.474

Review 6.  The Broad Spectrum of Human Natural Killer Cell Diversity.

Authors:  Aharon G Freud; Bethany L Mundy-Bosse; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

Review 7.  True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity.

Authors:  Luke Riggan; Aharon G Freud; Timothy E O'Sullivan
Journal:  Trends Immunol       Date:  2019-09-06       Impact factor: 16.687

8.  Human natural killer cells mediate adaptive immunity to viral antigens.

Authors:  Rana Nikzad; Laura S Angelo; Kevin Aviles-Padilla; Duy T Le; Vipul K Singh; Lynn Bimler; Milica Vukmanovic-Stejic; Elena Vendrame; Thanmayi Ranganath; Laura Simpson; Nancy L Haigwood; Catherine A Blish; Arne N Akbar; Silke Paust
Journal:  Sci Immunol       Date:  2019-05-10

9.  Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells.

Authors:  Sabrina Bianca Bennstein; Nadine Scherenschlich; Sandra Weinhold; Angela Riccarda Manser; Angela Noll; Katharina Raba; Gesine Kögler; Lutz Walter; Markus Uhrberg
Journal:  Stem Cells Transl Med       Date:  2021-01-21       Impact factor: 6.940

10.  TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma.

Authors:  Lihua Yu; Xiaoli Liu; Xinhui Wang; Fengna Yan; Peng Wang; Yuyong Jiang; Juan Du; Zhiyun Yang
Journal:  Oncoimmunology       Date:  2021-06-28       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.